Noticias de AXON_US
Noticias del mercado
Últimas noticias sobre AXON_US — 780 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Police officials plan on expanding their eyes in the sky with the integration of Skydio drones. But amending the city's contract with the previous company will cost millions.
Axon Enterprise Inc. stock underperforms Friday when compared to competitors
Axon Enterprise (AXON) closed at $430.11 in the latest trading session, marking a -3.35% move from the prior day.
At the close on September 24, 2026, Axon Enterprise stock stood at USD 434.62 after falling 3.55 per
Axon Enterprise Inc. stock underperforms Thursday when compared to competitors
Axon Enterprise stock traded at USD 437.35 on September 24, 2026, after a USD 1.15 billion convertib
At the close on September 23, 2026, Axon Enterprise stock stood at USD 450.61 after a 1.9 percent de
Get the latest Axon Enterprise, Inc. (AXON) stock news and headlines to help you in your trading and investment decisions.
Envestnet Portfolio Solutions Inc. grew its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 16,200.5% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 175,067 shares of the biotechnol
Axon Enterprise Inc. stock underperforms Wednesday when compared to competitors
Axon Enterprise stock closed at USD 459.32 on September 22, 2026, after rising 1.61 percent. Q2 reve
Envestnet Asset Management Inc. lifted its position in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 18,050.2% during the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 13,200,075 shares of the biotechnology company
In the closing of the recent trading day, Axon Enterprise (AXON) stood at $450.61, denoting a -1.9% move from the preceding trading day.
QRG Capital Management Inc. boosted its position in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 70,966.0% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 838,579 shares of the biotechnology company
Página 11 de 39